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ANAPHYLACTIC tests ar e among the manyimmunologicaltechniqueswhichhave
been used as analytical tools in the investigation of tumours. Makari (1955)
suggested that anaphylac tic phenomena could be used as the basis of a diagnostic
test for cancer. He pos tulated that there was an antigen common to all human
carcinomata and that th is antigen would be present in the serum ofpatients with
cancer. Guinea-pigs se nsitized with human tumour extracts should therefore
form antibodies not onl y to the species-specific antigens, the tissue antigens, and
the serum antigens in th e extract, but also to the tumour-specific antigens. The
isolated uteri of such g uinea-pigs should give Dale-Schultz reactions when chal-
lengedwith normal seru m, andthenwhenfullydesensitized tonormal serum should
give a further positiv e response with cancer serum. Makari did not do any
preliminary studies on the limits of sensitivity and accuracy of the Dale-Schultz
test used in this conte xt, but applied the test, ab initio, in the clinical field. He
claimed that it gave °6-8 per cent positives in known cancer cases. Burrows
(1958) reported similar results. Hackett and Gardonyi (1960), using a more
carefully considered tec hnique reported only 47 per cent positive results with
cancer sera and no false positives with normal sera. Less conclusive results were
reported by McEwen (19 59), Maass and Schniewind (1960) and Wittig, Teichmann
and Schneeweiss (1962).
The technique is a co mplicated one with many variables and it is not easy to
assess these conflicting reports in the literature. Negative results may mean
either that there are no t umour-specific antigens ofthe sort postulated or that the
tests used were not capab le ofdetecting such antigens, or both. It is not practic-
able to use anaphylactic tests to investigate the wider problem of the existence
of tumour-specific antige ns until more detailed information is available on the
limits of efficacy of such tests.
In previous studies (D ale, 1965a, b) some oftheassumptions on whichtheuse of
anaphylactic tests were ba sed were investigated andfound to be invalid. Certain
general operational limits were outlined within which the tests might possibly be
used to analyse antigen m ixtures. With these limits in mind a study has been
carried out to assess whethe r ifa cancer antigen were present in tissues and serum,
it could in fact be detecte d by anaphylactic techniques. A simple model of
Makari's diagnostic test was designed, using rat tissue and rat serum. A known
antigen, bovine y-globulin, was selected to represent the postulated tumour
antigen. Mock tumour ext racts were made up consisting of bovine y-globulin
(ByG) mixed in various prop ortions with an extract ofnormal rat liver. Guinea-
pigs were sensitized withthis mixture and after a suitable intervalthe anaphylactic
responses of isolated organs were investigated. The tests used were the Dale
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Schultz reaction, which had been used by many investigators, and the measure-
ment of histamine released from samples of chopped lung, which had not been
applied to this problem before. In the actual tests, pooled normal rat serum was
used for desensitization and then the response to mock cancer serum (normal rat
serum + ByG), was determined.
MATERIALS AND METHODS
Two groups of guinea-pigs were sensitized with different concentrations of
ByG in rat liver extract. A 25% extract was prepared by grinding up a weighed
quantity offresh ratliverwith sand, with a pestle and mortar, adding the requisite
quantity of distilled water and leaving the mixture to stand for 2 hours. NaCl
was then added to make the solution isotonic and the extract was centrifuged at
3000r.p.m. for 30minutes. Kjeldahl estimations oftotalN content ofthe extracts
were done and (assuming the N content in protein to be 16%) the protein concen-
tration was calculated. The following antigen mixtures were used for sensitiza-
tion:
Group I (7 guinea-pigs): 2-5 mg. rat liver protein + 50 ,pg. ByG
Group II (5 guinea-pigs): 500 ,ug. rat liver protein + 100 pg. ByG
The antigen mixture was emulsified with an equal quantity of incomplete or
complete Freund's adjuvants. In sensitizing the guinea-pigs the emulsion was
injected intradermally into 2 sites, behind each ear, a total volume of 0*5 ml. per
animal being given.
The details ofthe performance ofthe Dale-Schultz tests and the measurement
of histamine-release from chopped lung have been given in a previous paper
(Dale, 1965a).
Three " mock cancer " test sera, A, B and C, were made up for use in the tests.
These consisted of three different concentrations of ByG, 1 %, 0-1% and 0*01 %,
in pooled dialysed normal rat serum. The normal rat serum contained 50 mg./ml.
serum protein, andthe amountof" mock cancerantigen " wastherefore equivalent
to ), 310 and WOO of the normal serum proteins in test sera A, B and C respect-
ively. These sera were then diluted for the anaphylactic tests, as given below.
Both tests were done on all 12 animals.
The Dale-Schultz tests.-The loops ofileum were desensitized to normal serum
0.1% (final concentration) and then challenged with 0.1 % of one of the sera
containing ByG. With these dilutions the ByG concentrations were 10-5 inA,
10-6 in B and 10-7 in C. As in previous experiments a response to the second
antigen, the " test serum ", was only rated as positive if it were more than 10%
of the maximum response. With each guinea-pig the response to ByG alone in
the relevant concentrations, 10-7, 10-6 and 10-5, was tested in separate loops.
The hi8tamine-relea8e te8t8.-The basic technique ofmeasurement ofhistamine-
release from chopped lung was described by Mongar and Schild (1953, 1957, 1960).
Its general application for discrimination between antigens was discussed in a
previous paper (Dale, 1965b). In the present study the following protocol was
used:
Sample First challenge
numbers (partial desensitization) Second challenge
Control samples . 1, 2, 3, 4 . 0 1% normal serum . 0.1% normal serum
Test samples. . 5,6,7, 8 0 1%normalserum . 0.1% "test serum" A or B
Test samples . . 9,10,11,12 . O 1% normal serum . 0.1% "test erum" B or C
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All the samples were partially desensitized with 0.1 % (final concentration)
normal serum. Then, after washing, the amount of histamine released in the
two sets of test samples 5, 6, 7, 8 and 9, 10, 11, 12 by the test sera was compared
withthe amountreleased onsecondchallengewithnormal serumin controlsamples
1, 2, 3, 4 on a t-test. A result was rated as positive if there were a significant
difference between the control and the test samples at the level P 0-025. In
addition, histamine release with ByG alone, in the relevant concentrations, was
measured.
The solutions used were tested on normal tissues and found to cause no hista-
mine release and no Dale-Schultz reaction. The effects of ByG on the tissues of
a guinea-pig sensitized to liver extract alone, andthe effect ofnormal serum onthe
tissues of a guinea-pig sensitized to ByG alone, were tested and found to be
insignificant.
RESULTS
Bothtestswere done oneachguinea-pig. Alltheanimalsprovedtobe strongly
sensitized to the main antigens in the sensitizing mixture as evidenced by marked
reactions with rat serum in both tests. There were then two main questions to
be answered:
(a) Had the animals become sensitized to ByG as well?
(b) In those animals which showed evidence of sensitivity to ByG, was there
a positive anaphylactic response to the test serum after desensitization with
normal serum, i.e. was the ByG in the test serum detected by the anaphylactic
tests?
Dale-Schultz tests
The results are given in Table I and show the following:
(a) Senmitivity to ByG alone.-In group I, where the ByG had formed approxi-
mately 1 ofthe sensitizing mixture, only 3 out of 7 animals showedsensitivity to
TABLE I.-The Detection of Mock Cancer Antigen (ByG) in Rat Serum with the
Dale-Schultz Test
The Dale-Schultz response is given as percentage of the maximum response
Evidence ofsensitivity Dale-Schultz response (after
to " cancer antigen" prior desensitization to
alone normal serum 0.1%) with
Ratio of Guinea- A B C Test Test Test
sensitizing pig (ByG (ByG (ByG serum A serum B serum C
Group antigens No. 10-5) 10-6) 10-7) (0* 1%) (0.1%) (0. 1%)
I . ByG 50,ug. . 1 . - . 0(-) 0(-)
Liver 2 5 mg. . 2 . v V (-) O(-)
protein 3 . v >/ .. . 0(-) 0(-)
4 . . .0(- 0 () .
5 * -/ / * * 96(+) 65(+)
6 . . .0 () 0(- *-
7 . -.. . 0 () 0(-..
II . ByG 100,ug. . 8 . A/ A/ .. . 100(+) 92(+)
Liver 500,ug. . 9 . .. / . 65(+) 58(+) 15(+)
protein 10 . .A./ -/ * * 72(+) 20 (+)
11 . .. 1 V . .. 41(+) 7(-)
12 .. / * * 30(+) 30()616 M. MAUREEN DALE
TABLE II.-The Detection of Mock Cancer Antigen (ByG) in Rat Serum by the
Histamine-Release Test
Histamine release is given as percentage of total histamine* per sample. Each figure is the mean of
4 samples. The guinea-pigs were the same as those listed in Table I.
Evidence of sensitivity Histamine release (after prior
to " cancer antigen" desensitization to normal
alone serum 0 1%) with
Ratio of Guinea- A B C Normal Test Test Test
sensitizing pig (ByG (ByG (ByG serum serum A serum B serum C
Group antigens No. 10-5) 10-6) 10-7) (0*I%) (0*I%) (0. I%) (0. I%)
I ByG 50,ug. 1 v -I- 3-3 3-4 ) 3 (
Liver 2-5mg. 2 .. 2-9 34(-) 3-1(
protein 3 V V .. 3-8 4-9 (A) 5-3 (+)
4 .. 4-0 4 (-) 4-2(-)
5 V/ V 3-1 6-2(±) 4-6(+)
6 v V . 5-0 5-5 ) 5-1(
7 V - . 1-1 0-8 ) 0-6(
II ByG .100,ug. 8 V V 1-4 13-3(+) 10-2 (A)
Liver *500,ug. 9 .. V V 2-5 4-8(+) 7-7 (+)
protein 10 *- V V 3-1 .. 4-1(+) 3-5(
11 .. V V 1-2 .. 6-2(+) 2-8(±)
12 V/ 1-8 .. 3-6(±) 2-5(+)
* The "total histamine" refers to the histamine released by antigen + the residual histamine
(released by subsequent boiling of the tissue).
ByG. In group II, where ByG had formed 6 of the sensitizing mixture all 5
animals tested showed sensitivity to ByG.
(b) Response to the test sera after desensitization to normal serum.-In group I,
of the 3 animals in this group which had shown sensitivity to ByG when given
alone, only one animal gave a positive Dale-Schultz reaction with serum containing
ByG after desensitization with normal serum. In group II, all 5 animals used
showed sensitivity to ByGgiven alone, andafter desensitization withnormal serum,
2 out of 2 animals tested with " test serum A ", 5 out of 5 animals tested with
" test serum B ", and 3 out of 4 animals tested with " test serum C " gave positive
Dale-Schultz reactions.
Thus in group I, 12 out of 14 tests gave " false negative " results and in group
II, 1 out of 11 tests gave a " false negative " result.
Histamine-release tests
The results are given in Table II and show the following:
(a) Sensitivity to ByG alone.-In group I, 6 out of 7 animals, and in group II,
5 out of 5 animals had become sensitized to ByG.
(b) Response to the test sera after desensitization to normal serum.-In the smooth
muscle experiments, for each test the whole procedure has usually to be carried
out on one piece ofileum, because of the great variability between different loops.
When chopped lung is used, on the other hand, numerous strictly comparable
samples ofsensitizedtissue are available from each animal. The variation between
these samples is small and is moreover measurable, and its effects on the results
can be calculated. It is possible to use a larger number of samples for each test
and, having partially desensitized all of them with normal serum, to administer
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(the control samples) and compare the difference in histamine release between
the two sets ofsamples. The results obtained are amenable to statistical analysis,
and within limits, the sensitivity of the test can be increased by increasing the
number of samples. Using this procedure it was found that after desensitization
to normal serum in group I, of the 6 animals which had become sensitized to the
ByG, 4 showed no difference in histamine-release between the test samples and
the control samples, i.e. the test did not detect the ByG. In the remaining two
animals (No. 3 and 5) there was a positive response withtest serum, i.e. the percen-
tage histamine-release in the test samples was in each case significantly greater
than in the control samples on a t-test at the 2-5 % level. In group II, after
desensitization to normal serum, 5 out of 5 animals gave a positive response to
test serum B and 3 out of 4 gave a positive response to test serum C.
The measurements of the amount of histamine released in each sample were
done on the guinea-pig ileum preparation which is itself subject to variation, and
it is possible that this could affect the final results. It is feasible to examine this
possibility by doing an analysis of variance to determine whether the variation
between the readings on an individual lung sample is significantly different from
the variation between the results ofdifferent samples and/or the variation between
the results of different treatments (i.e. exposure to normal or cancer serum).
Analyses of variance were, in fact, done on the data from each experiment which
had given a positive result. The experimental design consisted ofnested samples
and the model of the analysis of variance was from Snedecor (1956). In each
case the variance ratios for
between-treatment variation and between-treatment variation
between-sample variation between-reading variation
were significant at the 5 % level. It was decided therefore that the differences
between treatments could be considered as real differences and not merely reflec-
tions of the variation between samples or the variation between readings.
DISCUSSION
The present study sought to answer the question: " If a tumour antigen
exists in a tumour and is also present in the serum-can it be detected by anaphy-
lactic tests? " A y-globulin was the substance chosen to represent the mock
cancer antigen because several investigators have reported the presence of addi-
tional globulins (not necessarily tumour-specific) in the serum of tumour-bearing
animals (Darcy, 1957; Miller and Bernfeld, 1960; Fine, Boffa and Zajdela,
1962; Abelev et al., 1963). It was recognized that a preparation of y-globulin
would be likely to consist of more than one physico-chemical entity, but it was
thought that for practical purposes the preparation could be treated as a single
antigen. Porter- (1960) has made the point that the antigenic specificity of
y-globulin in contrast to its physico-chemical properties shows a remarkable
homogenicity in any one species.
Considering the results as a whole, the answer to the question posed appears
to be that the antigen may very well not be detected by an anaphylactic test.
When the mock tumour antigen, though given in adequate sensitizing dosage,
formed a low proportion of the sensitizing mixture, it was very infrequently
detected even when present in a high concentration of the challenging serum. It
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was only consistently detected when it had been given in high absolute dosage
in, and had formed a relatively high proportion of, the sensitizing mixture, and
was subsequently present in a concentration of at least 10-3 in the challenging
serum. This does not accord with the claim made by Makari (1955) that these
anaphylactic tests are highly sensitive in this context. It might be argued that a
qualitative change in the serum ofthis magnitude could be detectedby less compli-
cated procedures.
The anaphylactic tests gave ahigh percentage of false negative results (i.e.
results which were negative when the antigen wa8 present). There appear to be
two main reasons for false negative results:
(a) There may be inadequate sensitization to the "tumour antigen " in some
animals. Many workers appear to have assumed that there would necessarily
be good sensitization to all antigens in an antigen mixture. In a previous study,
however (Dale, 1965b), it was pointed out that the presence of even one extra
antigen in the sensitizing mixture may decrease the sensitivity of an anaphylactic
test in detecting a particular antigen. It is apparent that this phenomenon
occurred in these experiments. In several animals in group I, for example, there
had been adequate sensitization to rat serum proteins but there had been no
sensitization to ByG although the amount of ByG given in the sensitizing mixture
was well within the dose range accepted as being reasonable for sensitization
even without adjuvants (Kabat and Mayer, 1961) and well above that shown
previously to give good sensitization when given alone (Dale, 1965a, b). The
Dale-Schultz testgavepoorerresults than the histamine-release test in this respect:
in group I, ofthe 7 animals sensitized to both ByG and ratliver extract, 4 showed
no sensitivity to ByG with the Dale-Schultz testwhile only 1 showed no sensitivity
to ByG with the histamine-release test.
(b) The tissues may be reasonably well sensitized to the mock tumour antigen,
but the process of desensitization may exhaust the "anaphylactic potential "
ofthe tissue. This phenomenon was pointed out in a previous study with a model
system ofmixed antigens (Dale, 1965b). In the present study a number ofanimals
in group I, for example, showed evidence ofgood sensitization to the mock cancer
antigen, ByG, asshownbytheresponses ofpreparations inwhichByGwas adminis-
tered alone. But when, in other preparations from the same animals, the tissues
were first desensitized with normal serum, there was no response subsequently to
serum containing ByG even when the concentration of ByG was 10 mg./ml. of
serum or equivalent to J of the normal serum proteins.
In as far as one can extrapolate from a simple model study of this sort to
experiments withrealtumours, itwould seem that it might conceivably be possible
to use anaphylactic tests in this sort of tumour antigen study, but the chances of
getting false negative results would be high unless the tumour antigen formed a
very substantial proportion ofthe antigenic material in the tumour extract. It is
probably unrealistic to expect that atumour antigen, ifpresent, would comprise as
muchas 15 % ofthe antigenic material inatumourextract. Equallyit isprobably
unrealistic to expect that in a tumour-bearing animal, a tumour antigen would be
present in the serum in concentrations of the order of 10-3-10-2. It would seem
therefore that unless such a tumour antigen were very powerfully antigenic,
anaphylactic tests would not be very useful tools in tumour antigen studies or in
diagnostic tests. If the tests were to be used at all in this type of analysis of
complex antigen mixtures, the histamine-release test, though more laborious todo,
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would be preferable to the Dale-Schultz test because the data obtained are amen-
able to statistical analysis and, within limits, the error of the technique canbe
calculated and taken into account.
SUMMARY
The efficacy of anaphylactic tests in detecting " tumour " antigen in serum
was investigated. A simple model of a tumour-antigen study was carried out
using rat tissue and rat serum, with bovine y-globulin (ByG) acting as a mock
cancer antigen.
It was found that ifByG (absolute dosage 100 ,g.) had formedJ ofthe antigen
mixture used for sensitization it was readily detected when present in a concen-
tration of 10-3 in the serum used for challenge, but not invariably detected in a
concentration of 1o-4. IfByG (absolute dosage 50 jug.) hadformed approximately
ofthe sensitizing mixture, it was infrequently detected even when present in the
challenging serum in a concentration of 10-2. It is concludedthat anaphylactic
tests used in this context do not have a very high sensitivity or discriminatory
capacity.
I am indebted to Professor H. 0. Schild and Dr. J. L. Mongar for valuable
advice. This work was supported by a grant from the British Empire Cancer
Campaign for Research.
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